Toggle Main Menu Toggle Search

Open Access padlockePrints

Associations of A Body Shape Index (ABSI) with Cancer Incidence, All-Cause, and at 23 Sites-Findings from the UK Biobank Prospective Cohort Study

Lookup NU author(s): Dr Fiona MalcomsonORCiD, Professor Linda Sharp, Professor John Mathers, Dr Carlos Celis Morales


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2021 American Association for Cancer Research. Background: Few studies have explored the emerging adiposity marker A Body Shape Index (ABSI) with cancer risk. This study investigated the associations between ABSI and the incidence of cancer at 23 sites and all cancer combined. Methods: Data from 442,610 participants from the UK Biobank prospective study were included in this study. ABSI was used as the exposure. Incidence of cancer at 23 sites was the outcome. Cox proportional hazard models were performed to explore the association of ABSI, and combined ABSI and body mass index (BMI) with cancer risk, after adjusting for multiple testing. Results: 36,961 individuals developed cancer during the 8.8 years median follow-up. In multivariable analyses, participants in the highest tertile of ABSI had higher risk of lung [HR, 1.58; 95% confidence interval (CI), 1.44-1.74], liver (HR, 1.45; 95% CI, 1.18-1.77), esophagus (HR, 1.32; 95% CI, 1.12-1.57), colorectal (HR, 1.19; 95% CI, 1.10-1.28), and breast (HR, 1.05; 95% CI, 1.04-1.17) cancers, and all cancers combined (HR, 1.11; 95% CI, 1.08-1.14) compared with the lowest tertile. These associations remained significant after adjustment for BMI. When ABSI was combined with BMI, participants in the highest ABSI who also had a BMI ≥ 25 kg/m2 were at higher risk of uterus, esophagus, liver, stomach, colorectal, and breast cancers, as well as all cancers combined, compared with those in the lowest ABSI tertile with a normal BMI. Conclusions: ABSI is associated with an increased risk of five cancers as well as all cancers combined, independently of BMI.

Publication metadata

Author(s): Parra-Soto S, Malcomson FC, Ho FK, Pell JP, Sharp L, Mathers JC, Celis-Morales C

Publication type: Article

Publication status: Published

Journal: Cancer Epidemiology Biomarkers and Prevention

Year: 2022

Volume: 31

Issue: 2

Pages: 315-324

Online publication date: 07/02/2022

Acceptance date: 22/11/2021

ISSN (print): 1055-9965

ISSN (electronic): 1538-7755

Publisher: American Association for Cancer Research Inc.


DOI: 10.1158/1055-9965.EPI-21-0591

PubMed id: 34853021


Altmetrics provided by Altmetric